|
NHEJ1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72650782559458E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62481139653892E-12 |
| Normal-vs-Stage2 |
1.850050E-02 |
| Normal-vs-Stage3 |
4.971100E-04 |
| Normal-vs-Stage4 |
3.355500E-03 |
| Stage1-vs-Stage2 |
3.328100E-02 |
| Stage1-vs-Stage3 |
2.682400E-03 |
| Stage1-vs-Stage4 |
5.982700E-04 |
| Stage2-vs-Stage3 |
9.606000E-01 |
| Stage2-vs-Stage4 |
7.426200E-01 |
| Stage3-vs-Stage4 |
7.136000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67377223192489E-12 |
| Normal-vs-AfricanAmerican |
1.813640E-02 |
| Normal-vs-Asian |
1.676960E-01 |
| Caucasian-vs-AfricanAmerican |
1.089570E-01 |
| Caucasian-vs-Asian |
8.649800E-01 |
| AfricanAmerican-vs-Asian |
6.110800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05040000031309E-07 |
| Normal-vs-Female |
1.82076576038526E-14 |
| Male-vs-Female |
2.28109999999004E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.269800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.11379852194705E-11 |
| Normal-vs-Age(61-80Yrs) |
1.01039998590124E-09 |
| Normal-vs-Age(81-100Yrs) |
6.024200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.321800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.259690E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.716200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.774600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.488400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.566000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.262400E-03 |
| Normal-vs-Grade 2 |
1.60982338570648E-14 |
| Normal-vs-Grade 3 |
2.67379995921857E-09 |
| Normal-vs-Grade 4 |
6.059000E-01 |
| Grade 1-vs-Grade 2 |
9.451600E-01 |
| Grade 1-vs-Grade 3 |
4.306800E-01 |
| Grade 1-vs-Grade 4 |
4.142300E-03 |
| Grade 2-vs-Grade 3 |
5.787800E-02 |
| Grade 2-vs-Grade 4 |
4.93899999787217E-08 |
| Grade 3-vs-Grade 4 |
9.79519999999567E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
3.201200E-01 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.31850033300441E-10 |
| Normal-vs-N1 |
9.484600E-01 |
| N0-vs-N1 |
8.781500E-03 |
|
|
